Where is Peptimmune headquartered?

Peptimmune is located in Cambridge, Massachusetts.

Who invested in Peptimmune?

Peptimmune has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Peptimmune?

Peptimmune closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

peptimmune.com

Peptimmune

Peptimmune is a drug company focused on the rare skin disease pemphigus vulgaris.

Business Model:

Revenue: $0

Employees: 11-50

Rankings

Industries / Tags:

Biotechnology

Medical

Pharmaceutical

Detailed Peptimmune Information

General Information

Geographic Data

Address:

City: Cambridge

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

series d

Raised Last:

$9M

Raised Total:

$93M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Peptimmune is a privately held clinical stage biotechnology company focused on utilizing both novel and proven technologies to improve the therapeutic management of chronic autoimmune and metabolic disorders. The company is developing second generation therapeutics that are expected to result in safer and more effective products for obesity, multiple sclerosis, rheumatoid arthritis and pemphigus vulgaris.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2008	Series D	5	$8.9M	Boston Medical Investors Covera Ventures MPM Capital New Enterprise Associates Silicon Valley Bank Boston Medical Investors Covera Ventures MPM Capital New Enterprise Associates Silicon Valley Bank
7/2005	Series C	4	$20.4M	MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures
3/2003	Series B	7	$41.2M	Boston Medical Investors Covera Ventures Hunt Ventures MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures Boston Medical Investors Covera Ventures Hunt Ventures MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures
6/2006	Series C		$0	Genzyme MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures Genzyme MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures
1/2002	Series A	2	$2.3M	OrbiMed Zero Stage Capital OrbiMed Zero Stage Capital
1/2008	Series D	5	$8.2M	Boston Medical Investors Covera Ventures MPM Capital New Enterprise Associates Silicon Valley Bank Boston Medical Investors Covera Ventures MPM Capital New Enterprise Associates Silicon Valley Bank
6/2006	Series C	5	$12M	Genzyme MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures Genzyme MPM Capital New Enterprise Associates Prism Venture Management Vanguard Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details